AdvaMed Calls For Guidance On Physician Investment In Device Firms
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is soliciting guidance from the HHS Office of Inspector General (OIG) regarding potentially unlawful arrangements between device manufacturers and physicians
You may also be interested in...
Inpatient Payment Proposal In Brief
ICD payments refined: CMS proposes to distinguish between procedures for implantable cardioverter defibrillator leads and ICD pulse generators in fiscal year 2009 with new Medicare severity diagnosis-related groups (MS-DRGs). Although the average length of hospital stay related to both types of procedures is similar, charges for cases of implantation or replacement of defibrillator leads average $42,896, while those for implantation or replacement of pulse generators average $72,866, according to a CMS analysis in its proposed hospital inpatient 1payment rule, released April 14. The proposed split in payment classifications was manufacturer-requested, CMS notes
Inpatient Payment Proposal In Brief
ICD payments refined: CMS proposes to distinguish between procedures for implantable cardioverter defibrillator leads and ICD pulse generators in fiscal year 2009 with new Medicare severity diagnosis-related groups (MS-DRGs). Although the average length of hospital stay related to both types of procedures is similar, charges for cases of implantation or replacement of defibrillator leads average $42,896, while those for implantation or replacement of pulse generators average $72,866, according to a CMS analysis in its proposed hospital inpatient 1payment rule, released April 14. The proposed split in payment classifications was manufacturer-requested, CMS notes
Physician Investment In Device Firms Warrants Government Scrutiny – OIG
In another sign of increasing government scrutiny of medical device industry sales and marketing practices, the HHS Office of Inspector General (OIG) indicated in an Oct. 6 letter that it is keeping a close eye on physician investments in device firms